Related Experiment Videos

Visual results after laser treatment for peripapillary choroidal neovascular membranes

P Turcotte1, M G Maguire, S L Fine

  • 1Retinal Vascular Center, Johns Hopkins Medical Institutions, Baltimore, Maryland.

Insights

Laser photocoagulation for peripapillary choroidal neovascular membranes rarely causes severe vision loss or visual field defects. Most patients experienced stable or improved visual acuity after treatment.

Area of Science:

  • Ophthalmology
  • Medical Laser Applications

Background:

  • Choroidal neovascularization (CNV) poses a risk to vision, particularly when involving the papillomacular bundle (PMB).
  • Laser photocoagulation is a treatment modality for CNV, but its safety in the PMB requires evaluation.

Observation:

  • A review of 28 eyes from 27 patients treated for PMB involvement of neovascular membranes was conducted.
  • Krypton red laser was the predominant treatment (75%), with some eyes receiving argon green or combined lasers.
  • Patient records were analyzed for visual acuity, visual field defects, and optic disc changes post-treatment.

Findings:

  • 75% of treated eyes maintained or improved visual acuity.
  • 11% of eyes experienced a loss of more than three lines of visual acuity.
  • 14% of eyes showed optic disc changes, and one eye developed a permanent arcuate scotoma.

Implications:

  • Laser photocoagulation for peripapillary CNV appears to be a relatively safe procedure with a low incidence of severe visual impairment.
  • The findings support the judicious use of laser photocoagulation in carefully selected cases involving the PMB.
  • Further research may refine treatment protocols to minimize risks and optimize outcomes for patients with CNV.

Related Concept Videos